Germany's BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa.
The EU's drug regulator has backed giving the BioNTech-Pfizer vaccine to children aged between 5 and 11. In Europe, vaccinating children has been a divisive issue – but many families will now be keen to get their kids jabbed.
Amid a new wave of infections, US health regulators have approved access to booster shots for all adults using either BioNTech-Pfizer or Moderna vaccines.
Germany holds onto Biontech jabs as its Moderna stock risks expiry- report whbl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whbl.com Daily Mail and Mail on Sunday newspapers.